Back

Statistical ranking of electromechanical dyssynchrony parameters for cardiac resynchronisation therapy

17 March 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Cardiac Resynchronization Therapy Cardiac Resynchronisation Therapy (CRT) EHRA Premium Access EHRA 2019

About the speaker

Photo
Doctor Serge Cazeau

Saint Joseph Hospital, Paris (France)

26 More presentations in this session

Presentation thumbnail
Left ventricular scar predicts remodeling in patients undergoing cardiac resynchronisation therapy - A retrospective analysis from a large tertiary centre
Ms K. Thomasson (Luton, GB)
Abstract Slides
Presentation thumbnail
Lead positioning for cardiac resynchronization therapy, a randomized trial comparing an active fixation bipolar left ventricular lead and a passive fixation quadripolar lead
Mr H. Keilegavlen (Bergen, NO)
Abstract Slides
Presentation thumbnail
Clinical outcome of cardiac resynchronization therapy in patients randomized to an active fixation bipolar left ventricular lead versus a passive quadripolar lead
Mr H. Keilegavlen (Bergen, NO)
Abstract Slides
Presentation thumbnail
Benefit of primary prophylactic ICD-therapy in nonischemic compared to ischemic cardiomyopathy with and without cardiac resynchronization therapy
Doctor T. Kleemann (Ludwigshafen, DE)
Abstract
Presentation thumbnail
Heart failure hospitalizations and associated costs in ICD/CRT-D recipients following device replacement or upgrade: insights from the DECODE registry
Doctor V. Zaca' (Siena, IT)
Abstract

Access the full session

Session thumbnail
Poster session 3 - Cardiac Resynchronization Therapy

The Event

Event poster

EHRA 2019

17 March - 19 March 2019
You may be interested in
thumbnail
Congress Presentation
Conduction system pacing in the current treatment of HFrEF patients
thumbnail
Congress Presentation
Device therapy: how to identify responders?
thumbnail
Congress Presentation
Cardiac resynchronisation therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources